Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
33,560
archived clinical trials in
Neurology

An Extension Protocol for Multiple Sclerosis Patients Who Participated in Genzyme-Sponsored Studies of Alemtuzumab
An Extension Protocol for Multiple Sclerosis Patients Who Participated in Genzyme-Sponsored Studies of Alemtuzumab
Status: Enrolling
Updated:  3/11/2016
The Corinne Goldsmith Dickinson Center for Multiple Sclerosis at Mount Sinai
mi
from
New York, NY
An Extension Protocol for Multiple Sclerosis Patients Who Participated in Genzyme-Sponsored Studies of Alemtuzumab
An Extension Protocol for Multiple Sclerosis Patients Who Participated in Genzyme-Sponsored Studies of Alemtuzumab
Status: Enrolling
Updated: 3/11/2016
The Corinne Goldsmith Dickinson Center for Multiple Sclerosis at Mount Sinai
mi
from
New York, NY
Click here to add this to my saved trials
An Extension Protocol for Multiple Sclerosis Patients Who Participated in Genzyme-Sponsored Studies of Alemtuzumab
An Extension Protocol for Multiple Sclerosis Patients Who Participated in Genzyme-Sponsored Studies of Alemtuzumab
Status: Enrolling
Updated:  3/11/2016
South Shore Neurologic Associates
mi
from
Patchogue, NY
An Extension Protocol for Multiple Sclerosis Patients Who Participated in Genzyme-Sponsored Studies of Alemtuzumab
An Extension Protocol for Multiple Sclerosis Patients Who Participated in Genzyme-Sponsored Studies of Alemtuzumab
Status: Enrolling
Updated: 3/11/2016
South Shore Neurologic Associates
mi
from
Patchogue, NY
Click here to add this to my saved trials
An Extension Protocol for Multiple Sclerosis Patients Who Participated in Genzyme-Sponsored Studies of Alemtuzumab
An Extension Protocol for Multiple Sclerosis Patients Who Participated in Genzyme-Sponsored Studies of Alemtuzumab
Status: Enrolling
Updated:  3/11/2016
Rochester Multiple Sclerosis Center
mi
from
Rochester, NY
An Extension Protocol for Multiple Sclerosis Patients Who Participated in Genzyme-Sponsored Studies of Alemtuzumab
An Extension Protocol for Multiple Sclerosis Patients Who Participated in Genzyme-Sponsored Studies of Alemtuzumab
Status: Enrolling
Updated: 3/11/2016
Rochester Multiple Sclerosis Center
mi
from
Rochester, NY
Click here to add this to my saved trials
An Extension Protocol for Multiple Sclerosis Patients Who Participated in Genzyme-Sponsored Studies of Alemtuzumab
An Extension Protocol for Multiple Sclerosis Patients Who Participated in Genzyme-Sponsored Studies of Alemtuzumab
Status: Enrolling
Updated:  3/11/2016
SUNY Upstate Medical University Department of Neurology
mi
from
Syracuse, NY
An Extension Protocol for Multiple Sclerosis Patients Who Participated in Genzyme-Sponsored Studies of Alemtuzumab
An Extension Protocol for Multiple Sclerosis Patients Who Participated in Genzyme-Sponsored Studies of Alemtuzumab
Status: Enrolling
Updated: 3/11/2016
SUNY Upstate Medical University Department of Neurology
mi
from
Syracuse, NY
Click here to add this to my saved trials
An Extension Protocol for Multiple Sclerosis Patients Who Participated in Genzyme-Sponsored Studies of Alemtuzumab
An Extension Protocol for Multiple Sclerosis Patients Who Participated in Genzyme-Sponsored Studies of Alemtuzumab
Status: Enrolling
Updated:  3/11/2016
University of North Carolina at Chapel Hill
mi
from
Chapel Hill, NC
An Extension Protocol for Multiple Sclerosis Patients Who Participated in Genzyme-Sponsored Studies of Alemtuzumab
An Extension Protocol for Multiple Sclerosis Patients Who Participated in Genzyme-Sponsored Studies of Alemtuzumab
Status: Enrolling
Updated: 3/11/2016
University of North Carolina at Chapel Hill
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
An Extension Protocol for Multiple Sclerosis Patients Who Participated in Genzyme-Sponsored Studies of Alemtuzumab
An Extension Protocol for Multiple Sclerosis Patients Who Participated in Genzyme-Sponsored Studies of Alemtuzumab
Status: Enrolling
Updated:  3/11/2016
Wake Forest University Health Science Department of Neurology
mi
from
Winston Salem, NC
An Extension Protocol for Multiple Sclerosis Patients Who Participated in Genzyme-Sponsored Studies of Alemtuzumab
An Extension Protocol for Multiple Sclerosis Patients Who Participated in Genzyme-Sponsored Studies of Alemtuzumab
Status: Enrolling
Updated: 3/11/2016
Wake Forest University Health Science Department of Neurology
mi
from
Winston Salem, NC
Click here to add this to my saved trials
An Extension Protocol for Multiple Sclerosis Patients Who Participated in Genzyme-Sponsored Studies of Alemtuzumab
An Extension Protocol for Multiple Sclerosis Patients Who Participated in Genzyme-Sponsored Studies of Alemtuzumab
Status: Enrolling
Updated:  3/11/2016
Cleveland Clinic Foundation
mi
from
Cleveland, OH
An Extension Protocol for Multiple Sclerosis Patients Who Participated in Genzyme-Sponsored Studies of Alemtuzumab
An Extension Protocol for Multiple Sclerosis Patients Who Participated in Genzyme-Sponsored Studies of Alemtuzumab
Status: Enrolling
Updated: 3/11/2016
Cleveland Clinic Foundation
mi
from
Cleveland, OH
Click here to add this to my saved trials
An Extension Protocol for Multiple Sclerosis Patients Who Participated in Genzyme-Sponsored Studies of Alemtuzumab
An Extension Protocol for Multiple Sclerosis Patients Who Participated in Genzyme-Sponsored Studies of Alemtuzumab
Status: Enrolling
Updated:  3/11/2016
Oak Clinic for Multiple Sclerosis
mi
from
Uniontown, OH
An Extension Protocol for Multiple Sclerosis Patients Who Participated in Genzyme-Sponsored Studies of Alemtuzumab
An Extension Protocol for Multiple Sclerosis Patients Who Participated in Genzyme-Sponsored Studies of Alemtuzumab
Status: Enrolling
Updated: 3/11/2016
Oak Clinic for Multiple Sclerosis
mi
from
Uniontown, OH
Click here to add this to my saved trials
An Extension Protocol for Multiple Sclerosis Patients Who Participated in Genzyme-Sponsored Studies of Alemtuzumab
An Extension Protocol for Multiple Sclerosis Patients Who Participated in Genzyme-Sponsored Studies of Alemtuzumab
Status: Enrolling
Updated:  3/11/2016
OMRF Multiple Sclerosis Center of Excellence
mi
from
Oklahoma City, OK
An Extension Protocol for Multiple Sclerosis Patients Who Participated in Genzyme-Sponsored Studies of Alemtuzumab
An Extension Protocol for Multiple Sclerosis Patients Who Participated in Genzyme-Sponsored Studies of Alemtuzumab
Status: Enrolling
Updated: 3/11/2016
OMRF Multiple Sclerosis Center of Excellence
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
An Extension Protocol for Multiple Sclerosis Patients Who Participated in Genzyme-Sponsored Studies of Alemtuzumab
An Extension Protocol for Multiple Sclerosis Patients Who Participated in Genzyme-Sponsored Studies of Alemtuzumab
Status: Enrolling
Updated:  3/11/2016
Lehigh Valley Hospital - Neurosciences and Pain Research
mi
from
Allentown, PA
An Extension Protocol for Multiple Sclerosis Patients Who Participated in Genzyme-Sponsored Studies of Alemtuzumab
An Extension Protocol for Multiple Sclerosis Patients Who Participated in Genzyme-Sponsored Studies of Alemtuzumab
Status: Enrolling
Updated: 3/11/2016
Lehigh Valley Hospital - Neurosciences and Pain Research
mi
from
Allentown, PA
Click here to add this to my saved trials
An Extension Protocol for Multiple Sclerosis Patients Who Participated in Genzyme-Sponsored Studies of Alemtuzumab
An Extension Protocol for Multiple Sclerosis Patients Who Participated in Genzyme-Sponsored Studies of Alemtuzumab
Status: Enrolling
Updated:  3/11/2016
Rhode Island Hospital MS Center - The Neurology Foundation, Inc
mi
from
Providence, RI
An Extension Protocol for Multiple Sclerosis Patients Who Participated in Genzyme-Sponsored Studies of Alemtuzumab
An Extension Protocol for Multiple Sclerosis Patients Who Participated in Genzyme-Sponsored Studies of Alemtuzumab
Status: Enrolling
Updated: 3/11/2016
Rhode Island Hospital MS Center - The Neurology Foundation, Inc
mi
from
Providence, RI
Click here to add this to my saved trials
An Extension Protocol for Multiple Sclerosis Patients Who Participated in Genzyme-Sponsored Studies of Alemtuzumab
An Extension Protocol for Multiple Sclerosis Patients Who Participated in Genzyme-Sponsored Studies of Alemtuzumab
Status: Enrolling
Updated:  3/11/2016
Neurology Clinic, PC
mi
from
Cordova, TN
An Extension Protocol for Multiple Sclerosis Patients Who Participated in Genzyme-Sponsored Studies of Alemtuzumab
An Extension Protocol for Multiple Sclerosis Patients Who Participated in Genzyme-Sponsored Studies of Alemtuzumab
Status: Enrolling
Updated: 3/11/2016
Neurology Clinic, PC
mi
from
Cordova, TN
Click here to add this to my saved trials
An Extension Protocol for Multiple Sclerosis Patients Who Participated in Genzyme-Sponsored Studies of Alemtuzumab
An Extension Protocol for Multiple Sclerosis Patients Who Participated in Genzyme-Sponsored Studies of Alemtuzumab
Status: Enrolling
Updated:  3/11/2016
Advanced Neurosciences Institute
mi
from
Franklin, TN
An Extension Protocol for Multiple Sclerosis Patients Who Participated in Genzyme-Sponsored Studies of Alemtuzumab
An Extension Protocol for Multiple Sclerosis Patients Who Participated in Genzyme-Sponsored Studies of Alemtuzumab
Status: Enrolling
Updated: 3/11/2016
Advanced Neurosciences Institute
mi
from
Franklin, TN
Click here to add this to my saved trials
An Extension Protocol for Multiple Sclerosis Patients Who Participated in Genzyme-Sponsored Studies of Alemtuzumab
An Extension Protocol for Multiple Sclerosis Patients Who Participated in Genzyme-Sponsored Studies of Alemtuzumab
Status: Enrolling
Updated:  3/11/2016
Hope Neurology
mi
from
Knoxville, TN
An Extension Protocol for Multiple Sclerosis Patients Who Participated in Genzyme-Sponsored Studies of Alemtuzumab
An Extension Protocol for Multiple Sclerosis Patients Who Participated in Genzyme-Sponsored Studies of Alemtuzumab
Status: Enrolling
Updated: 3/11/2016
Hope Neurology
mi
from
Knoxville, TN
Click here to add this to my saved trials
An Extension Protocol for Multiple Sclerosis Patients Who Participated in Genzyme-Sponsored Studies of Alemtuzumab
An Extension Protocol for Multiple Sclerosis Patients Who Participated in Genzyme-Sponsored Studies of Alemtuzumab
Status: Enrolling
Updated:  3/11/2016
Vanderbilt University Medical Center
mi
from
Nashville, TN
An Extension Protocol for Multiple Sclerosis Patients Who Participated in Genzyme-Sponsored Studies of Alemtuzumab
An Extension Protocol for Multiple Sclerosis Patients Who Participated in Genzyme-Sponsored Studies of Alemtuzumab
Status: Enrolling
Updated: 3/11/2016
Vanderbilt University Medical Center
mi
from
Nashville, TN
Click here to add this to my saved trials
An Extension Protocol for Multiple Sclerosis Patients Who Participated in Genzyme-Sponsored Studies of Alemtuzumab
An Extension Protocol for Multiple Sclerosis Patients Who Participated in Genzyme-Sponsored Studies of Alemtuzumab
Status: Enrolling
Updated:  3/11/2016
Baylor College of Medicine, Maxine Mesinger MS Clinic
mi
from
Houston, TX
An Extension Protocol for Multiple Sclerosis Patients Who Participated in Genzyme-Sponsored Studies of Alemtuzumab
An Extension Protocol for Multiple Sclerosis Patients Who Participated in Genzyme-Sponsored Studies of Alemtuzumab
Status: Enrolling
Updated: 3/11/2016
Baylor College of Medicine, Maxine Mesinger MS Clinic
mi
from
Houston, TX
Click here to add this to my saved trials
An Extension Protocol for Multiple Sclerosis Patients Who Participated in Genzyme-Sponsored Studies of Alemtuzumab
An Extension Protocol for Multiple Sclerosis Patients Who Participated in Genzyme-Sponsored Studies of Alemtuzumab
Status: Enrolling
Updated:  3/11/2016
Central Texas Neurology Consultants, P.A.
mi
from
Round Rock, TX
An Extension Protocol for Multiple Sclerosis Patients Who Participated in Genzyme-Sponsored Studies of Alemtuzumab
An Extension Protocol for Multiple Sclerosis Patients Who Participated in Genzyme-Sponsored Studies of Alemtuzumab
Status: Enrolling
Updated: 3/11/2016
Central Texas Neurology Consultants, P.A.
mi
from
Round Rock, TX
Click here to add this to my saved trials
An Extension Protocol for Multiple Sclerosis Patients Who Participated in Genzyme-Sponsored Studies of Alemtuzumab
An Extension Protocol for Multiple Sclerosis Patients Who Participated in Genzyme-Sponsored Studies of Alemtuzumab
Status: Enrolling
Updated:  3/11/2016
Integra Clinical Research
mi
from
San Antonio, TX
An Extension Protocol for Multiple Sclerosis Patients Who Participated in Genzyme-Sponsored Studies of Alemtuzumab
An Extension Protocol for Multiple Sclerosis Patients Who Participated in Genzyme-Sponsored Studies of Alemtuzumab
Status: Enrolling
Updated: 3/11/2016
Integra Clinical Research
mi
from
San Antonio, TX
Click here to add this to my saved trials
An Extension Protocol for Multiple Sclerosis Patients Who Participated in Genzyme-Sponsored Studies of Alemtuzumab
An Extension Protocol for Multiple Sclerosis Patients Who Participated in Genzyme-Sponsored Studies of Alemtuzumab
Status: Enrolling
Updated:  3/11/2016
Neurology Center of San Antonio
mi
from
San Antonio, TX
An Extension Protocol for Multiple Sclerosis Patients Who Participated in Genzyme-Sponsored Studies of Alemtuzumab
An Extension Protocol for Multiple Sclerosis Patients Who Participated in Genzyme-Sponsored Studies of Alemtuzumab
Status: Enrolling
Updated: 3/11/2016
Neurology Center of San Antonio
mi
from
San Antonio, TX
Click here to add this to my saved trials
An Extension Protocol for Multiple Sclerosis Patients Who Participated in Genzyme-Sponsored Studies of Alemtuzumab
An Extension Protocol for Multiple Sclerosis Patients Who Participated in Genzyme-Sponsored Studies of Alemtuzumab
Status: Enrolling
Updated:  3/11/2016
MS Center of Greater Washington
mi
from
Vienna, VA
An Extension Protocol for Multiple Sclerosis Patients Who Participated in Genzyme-Sponsored Studies of Alemtuzumab
An Extension Protocol for Multiple Sclerosis Patients Who Participated in Genzyme-Sponsored Studies of Alemtuzumab
Status: Enrolling
Updated: 3/11/2016
MS Center of Greater Washington
mi
from
Vienna, VA
Click here to add this to my saved trials
An Extension Protocol for Multiple Sclerosis Patients Who Participated in Genzyme-Sponsored Studies of Alemtuzumab
An Extension Protocol for Multiple Sclerosis Patients Who Participated in Genzyme-Sponsored Studies of Alemtuzumab
Status: Enrolling
Updated:  3/11/2016
Swedish Medical MS Center
mi
from
Seattle, WA
An Extension Protocol for Multiple Sclerosis Patients Who Participated in Genzyme-Sponsored Studies of Alemtuzumab
An Extension Protocol for Multiple Sclerosis Patients Who Participated in Genzyme-Sponsored Studies of Alemtuzumab
Status: Enrolling
Updated: 3/11/2016
Swedish Medical MS Center
mi
from
Seattle, WA
Click here to add this to my saved trials
An Extension Protocol for Multiple Sclerosis Patients Who Participated in Genzyme-Sponsored Studies of Alemtuzumab
An Extension Protocol for Multiple Sclerosis Patients Who Participated in Genzyme-Sponsored Studies of Alemtuzumab
Status: Enrolling
Updated:  3/11/2016
DIABAID
mi
from
Buenos Aires,
An Extension Protocol for Multiple Sclerosis Patients Who Participated in Genzyme-Sponsored Studies of Alemtuzumab
An Extension Protocol for Multiple Sclerosis Patients Who Participated in Genzyme-Sponsored Studies of Alemtuzumab
Status: Enrolling
Updated: 3/11/2016
DIABAID
mi
from
Buenos Aires,
Click here to add this to my saved trials
Efficacy, Safety, and Tolerability Rollover Study of Eteplirsen in Subjects With Duchenne Muscular Dystrophy
Open-Label, Multiple-Dose, Efficacy, Safety, and Tolerability Study of Eteplirsen in Subjects With Duchenne Muscular Dystrophy Who Participated in Study 4658-US-201
Status: Enrolling
Updated:  3/11/2016
Miller Children's Hospital
mi
from
Long Beach, CA
Efficacy, Safety, and Tolerability Rollover Study of Eteplirsen in Subjects With Duchenne Muscular Dystrophy
Open-Label, Multiple-Dose, Efficacy, Safety, and Tolerability Study of Eteplirsen in Subjects With Duchenne Muscular Dystrophy Who Participated in Study 4658-US-201
Status: Enrolling
Updated: 3/11/2016
Miller Children's Hospital
mi
from
Long Beach, CA
Click here to add this to my saved trials
Efficacy, Safety, and Tolerability Rollover Study of Eteplirsen in Subjects With Duchenne Muscular Dystrophy
Open-Label, Multiple-Dose, Efficacy, Safety, and Tolerability Study of Eteplirsen in Subjects With Duchenne Muscular Dystrophy Who Participated in Study 4658-US-201
Status: Enrolling
Updated:  3/11/2016
University of Florida Clinical Research Center
mi
from
Gainesville, FL
Efficacy, Safety, and Tolerability Rollover Study of Eteplirsen in Subjects With Duchenne Muscular Dystrophy
Open-Label, Multiple-Dose, Efficacy, Safety, and Tolerability Study of Eteplirsen in Subjects With Duchenne Muscular Dystrophy Who Participated in Study 4658-US-201
Status: Enrolling
Updated: 3/11/2016
University of Florida Clinical Research Center
mi
from
Gainesville, FL
Click here to add this to my saved trials
Efficacy, Safety, and Tolerability Rollover Study of Eteplirsen in Subjects With Duchenne Muscular Dystrophy
Open-Label, Multiple-Dose, Efficacy, Safety, and Tolerability Study of Eteplirsen in Subjects With Duchenne Muscular Dystrophy Who Participated in Study 4658-US-201
Status: Enrolling
Updated:  3/11/2016
Rush University Medical Center
mi
from
Chicago, IL
Efficacy, Safety, and Tolerability Rollover Study of Eteplirsen in Subjects With Duchenne Muscular Dystrophy
Open-Label, Multiple-Dose, Efficacy, Safety, and Tolerability Study of Eteplirsen in Subjects With Duchenne Muscular Dystrophy Who Participated in Study 4658-US-201
Status: Enrolling
Updated: 3/11/2016
Rush University Medical Center
mi
from
Chicago, IL
Click here to add this to my saved trials
Efficacy, Safety, and Tolerability Rollover Study of Eteplirsen in Subjects With Duchenne Muscular Dystrophy
Open-Label, Multiple-Dose, Efficacy, Safety, and Tolerability Study of Eteplirsen in Subjects With Duchenne Muscular Dystrophy Who Participated in Study 4658-US-201
Status: Enrolling
Updated:  3/11/2016
Massachusetts General Hospital
mi
from
Boston, MA
Efficacy, Safety, and Tolerability Rollover Study of Eteplirsen in Subjects With Duchenne Muscular Dystrophy
Open-Label, Multiple-Dose, Efficacy, Safety, and Tolerability Study of Eteplirsen in Subjects With Duchenne Muscular Dystrophy Who Participated in Study 4658-US-201
Status: Enrolling
Updated: 3/11/2016
Massachusetts General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
Efficacy, Safety, and Tolerability Rollover Study of Eteplirsen in Subjects With Duchenne Muscular Dystrophy
Open-Label, Multiple-Dose, Efficacy, Safety, and Tolerability Study of Eteplirsen in Subjects With Duchenne Muscular Dystrophy Who Participated in Study 4658-US-201
Status: Enrolling
Updated:  3/11/2016
Washington University Medical School
mi
from
St. Louis, MO
Efficacy, Safety, and Tolerability Rollover Study of Eteplirsen in Subjects With Duchenne Muscular Dystrophy
Open-Label, Multiple-Dose, Efficacy, Safety, and Tolerability Study of Eteplirsen in Subjects With Duchenne Muscular Dystrophy Who Participated in Study 4658-US-201
Status: Enrolling
Updated: 3/11/2016
Washington University Medical School
mi
from
St. Louis, MO
Click here to add this to my saved trials
Efficacy, Safety, and Tolerability Rollover Study of Eteplirsen in Subjects With Duchenne Muscular Dystrophy
Open-Label, Multiple-Dose, Efficacy, Safety, and Tolerability Study of Eteplirsen in Subjects With Duchenne Muscular Dystrophy Who Participated in Study 4658-US-201
Status: Enrolling
Updated:  3/11/2016
Summerwood Pediatrics/Infusacare Medical Services
mi
from
Liverpool, NY
Efficacy, Safety, and Tolerability Rollover Study of Eteplirsen in Subjects With Duchenne Muscular Dystrophy
Open-Label, Multiple-Dose, Efficacy, Safety, and Tolerability Study of Eteplirsen in Subjects With Duchenne Muscular Dystrophy Who Participated in Study 4658-US-201
Status: Enrolling
Updated: 3/11/2016
Summerwood Pediatrics/Infusacare Medical Services
mi
from
Liverpool, NY
Click here to add this to my saved trials
Efficacy, Safety, and Tolerability Rollover Study of Eteplirsen in Subjects With Duchenne Muscular Dystrophy
Open-Label, Multiple-Dose, Efficacy, Safety, and Tolerability Study of Eteplirsen in Subjects With Duchenne Muscular Dystrophy Who Participated in Study 4658-US-201
Status: Enrolling
Updated:  3/11/2016
Levine Children's Hospital
mi
from
Charlotte, NC
Efficacy, Safety, and Tolerability Rollover Study of Eteplirsen in Subjects With Duchenne Muscular Dystrophy
Open-Label, Multiple-Dose, Efficacy, Safety, and Tolerability Study of Eteplirsen in Subjects With Duchenne Muscular Dystrophy Who Participated in Study 4658-US-201
Status: Enrolling
Updated: 3/11/2016
Levine Children's Hospital
mi
from
Charlotte, NC
Click here to add this to my saved trials
Efficacy, Safety, and Tolerability Rollover Study of Eteplirsen in Subjects With Duchenne Muscular Dystrophy
Open-Label, Multiple-Dose, Efficacy, Safety, and Tolerability Study of Eteplirsen in Subjects With Duchenne Muscular Dystrophy Who Participated in Study 4658-US-201
Status: Enrolling
Updated:  3/11/2016
Nationwide Children's Hospital
mi
from
Columbus, OH
Efficacy, Safety, and Tolerability Rollover Study of Eteplirsen in Subjects With Duchenne Muscular Dystrophy
Open-Label, Multiple-Dose, Efficacy, Safety, and Tolerability Study of Eteplirsen in Subjects With Duchenne Muscular Dystrophy Who Participated in Study 4658-US-201
Status: Enrolling
Updated: 3/11/2016
Nationwide Children's Hospital
mi
from
Columbus, OH
Click here to add this to my saved trials
Efficacy, Safety, and Tolerability Rollover Study of Eteplirsen in Subjects With Duchenne Muscular Dystrophy
Open-Label, Multiple-Dose, Efficacy, Safety, and Tolerability Study of Eteplirsen in Subjects With Duchenne Muscular Dystrophy Who Participated in Study 4658-US-201
Status: Enrolling
Updated:  3/11/2016
Children's Hospital of Pittsburgh of UPMC
mi
from
Pittsburgh, PA
Efficacy, Safety, and Tolerability Rollover Study of Eteplirsen in Subjects With Duchenne Muscular Dystrophy
Open-Label, Multiple-Dose, Efficacy, Safety, and Tolerability Study of Eteplirsen in Subjects With Duchenne Muscular Dystrophy Who Participated in Study 4658-US-201
Status: Enrolling
Updated: 3/11/2016
Children's Hospital of Pittsburgh of UPMC
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Efficacy, Safety, and Tolerability Rollover Study of Eteplirsen in Subjects With Duchenne Muscular Dystrophy
Open-Label, Multiple-Dose, Efficacy, Safety, and Tolerability Study of Eteplirsen in Subjects With Duchenne Muscular Dystrophy Who Participated in Study 4658-US-201
Status: Enrolling
Updated:  3/11/2016
Children's Specialty Group, Pediatric Neurology
mi
from
Norfolk, VA
Efficacy, Safety, and Tolerability Rollover Study of Eteplirsen in Subjects With Duchenne Muscular Dystrophy
Open-Label, Multiple-Dose, Efficacy, Safety, and Tolerability Study of Eteplirsen in Subjects With Duchenne Muscular Dystrophy Who Participated in Study 4658-US-201
Status: Enrolling
Updated: 3/11/2016
Children's Specialty Group, Pediatric Neurology
mi
from
Norfolk, VA
Click here to add this to my saved trials
Efficacy, Safety, and Tolerability Rollover Study of Eteplirsen in Subjects With Duchenne Muscular Dystrophy
Open-Label, Multiple-Dose, Efficacy, Safety, and Tolerability Study of Eteplirsen in Subjects With Duchenne Muscular Dystrophy Who Participated in Study 4658-US-201
Status: Enrolling
Updated:  3/11/2016
Osceola Medical Center
mi
from
Osceola, WI
Efficacy, Safety, and Tolerability Rollover Study of Eteplirsen in Subjects With Duchenne Muscular Dystrophy
Open-Label, Multiple-Dose, Efficacy, Safety, and Tolerability Study of Eteplirsen in Subjects With Duchenne Muscular Dystrophy Who Participated in Study 4658-US-201
Status: Enrolling
Updated: 3/11/2016
Osceola Medical Center
mi
from
Osceola, WI
Click here to add this to my saved trials
Imaging Guided Patient Selection for Interventional Revascularization Therapy
The START Trial: Clinical Outcome in Acute Stroke Treatment After Imaging Guided Patient Selection for Interventional Revascularization Therapy
Status: Enrolling
Updated:  3/14/2016
Medical University of South Carolina
mi
from
Charleston, SC
Imaging Guided Patient Selection for Interventional Revascularization Therapy
The START Trial: Clinical Outcome in Acute Stroke Treatment After Imaging Guided Patient Selection for Interventional Revascularization Therapy
Status: Enrolling
Updated: 3/14/2016
Medical University of South Carolina
mi
from
Charleston, SC
Click here to add this to my saved trials
A Clinical Trial to Assess the Acute Safety and Functional Outcome and Recovery After STROKE: The FIRST Trial
Functional Outcome and Recovery After STROKE: The FIRST Trial
Status: Enrolling
Updated:  3/14/2016
Texas Stroke Institute
mi
from
Plano, TX
A Clinical Trial to Assess the Acute Safety and Functional Outcome and Recovery After STROKE: The FIRST Trial
Functional Outcome and Recovery After STROKE: The FIRST Trial
Status: Enrolling
Updated: 3/14/2016
Texas Stroke Institute
mi
from
Plano, TX
Click here to add this to my saved trials
A Clinical Trial to Assess the Acute Safety and Functional Outcome and Recovery After STROKE: The FIRST Trial
Functional Outcome and Recovery After STROKE: The FIRST Trial
Status: Enrolling
Updated:  3/14/2016
Queen Mary Hospital
mi
from
Hong Kong,
A Clinical Trial to Assess the Acute Safety and Functional Outcome and Recovery After STROKE: The FIRST Trial
Functional Outcome and Recovery After STROKE: The FIRST Trial
Status: Enrolling
Updated: 3/14/2016
Queen Mary Hospital
mi
from
Hong Kong,
Click here to add this to my saved trials
Carotid Artery Stenting Outcomes in the Standard Risk Population for Carotid Endarterectomy
CANOPY: Carotid Artery Stenting Outcomes in the Standard Risk Population for Carotid Endarterectomy
Status: Enrolling
Updated:  3/14/2016
Abbott Vascular
mi
from
Santa Clara, CA
Carotid Artery Stenting Outcomes in the Standard Risk Population for Carotid Endarterectomy
CANOPY: Carotid Artery Stenting Outcomes in the Standard Risk Population for Carotid Endarterectomy
Status: Enrolling
Updated: 3/14/2016
Abbott Vascular
mi
from
Santa Clara, CA
Click here to add this to my saved trials
A Double-Blind Comparison of Naltrexone and Placebo in Adults With Attention Deficit Hyperactivity Disorder
A Double-Blind Comparison of Naltrexone and Placebo in Adults With Attention Deficit Hyperactivity Disorder
Status: Enrolling
Updated:  3/14/2016
Massachusetts General Hospital
mi
from
Cambridge, MA
A Double-Blind Comparison of Naltrexone and Placebo in Adults With Attention Deficit Hyperactivity Disorder
A Double-Blind Comparison of Naltrexone and Placebo in Adults With Attention Deficit Hyperactivity Disorder
Status: Enrolling
Updated: 3/14/2016
Massachusetts General Hospital
mi
from
Cambridge, MA
Click here to add this to my saved trials
An Open-Label Study of Naltrexone in Adults With Attention Deficit Hyperactivity Disorder.
An Open-Label Study of Naltrexone in Adults With Attention Deficit Hyperactivity Disorder.
Status: Enrolling
Updated:  3/14/2016
Massachusetts General Hospital
mi
from
Boston, MA
An Open-Label Study of Naltrexone in Adults With Attention Deficit Hyperactivity Disorder.
An Open-Label Study of Naltrexone in Adults With Attention Deficit Hyperactivity Disorder.
Status: Enrolling
Updated: 3/14/2016
Massachusetts General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
Neonatal Erythropoietin And Therapeutic Hypothermia Outcomes in Newborn Brain Injury (NEATO)
Neonatal Erythropoietin And Therapeutic Hypothermia Outcomes Study
Status: Enrolling
Updated:  3/14/2016
Arkansas Children's Hospital Research Institute
mi
from
Little Rock, AR
Neonatal Erythropoietin And Therapeutic Hypothermia Outcomes in Newborn Brain Injury (NEATO)
Neonatal Erythropoietin And Therapeutic Hypothermia Outcomes Study
Status: Enrolling
Updated: 3/14/2016
Arkansas Children's Hospital Research Institute
mi
from
Little Rock, AR
Click here to add this to my saved trials
Neonatal Erythropoietin And Therapeutic Hypothermia Outcomes in Newborn Brain Injury (NEATO)
Neonatal Erythropoietin And Therapeutic Hypothermia Outcomes Study
Status: Enrolling
Updated:  3/14/2016
Kaiser Permanente Santa Clara
mi
from
Santa Clara, CA
Neonatal Erythropoietin And Therapeutic Hypothermia Outcomes in Newborn Brain Injury (NEATO)
Neonatal Erythropoietin And Therapeutic Hypothermia Outcomes Study
Status: Enrolling
Updated: 3/14/2016
Kaiser Permanente Santa Clara
mi
from
Santa Clara, CA
Click here to add this to my saved trials
Neonatal Erythropoietin And Therapeutic Hypothermia Outcomes in Newborn Brain Injury (NEATO)
Neonatal Erythropoietin And Therapeutic Hypothermia Outcomes Study
Status: Enrolling
Updated:  3/14/2016
Children's National Medical Center
mi
from
Washington DC,
Neonatal Erythropoietin And Therapeutic Hypothermia Outcomes in Newborn Brain Injury (NEATO)
Neonatal Erythropoietin And Therapeutic Hypothermia Outcomes Study
Status: Enrolling
Updated: 3/14/2016
Children's National Medical Center
mi
from
Washington DC,
Click here to add this to my saved trials
Neonatal Erythropoietin And Therapeutic Hypothermia Outcomes in Newborn Brain Injury (NEATO)
Neonatal Erythropoietin And Therapeutic Hypothermia Outcomes Study
Status: Enrolling
Updated:  3/14/2016
Washington University
mi
from
St. Louis, MO
Neonatal Erythropoietin And Therapeutic Hypothermia Outcomes in Newborn Brain Injury (NEATO)
Neonatal Erythropoietin And Therapeutic Hypothermia Outcomes Study
Status: Enrolling
Updated: 3/14/2016
Washington University
mi
from
St. Louis, MO
Click here to add this to my saved trials
Neonatal Erythropoietin And Therapeutic Hypothermia Outcomes in Newborn Brain Injury (NEATO)
Neonatal Erythropoietin And Therapeutic Hypothermia Outcomes Study
Status: Enrolling
Updated:  3/14/2016
Seattle Children's Hospital
mi
from
Seattle, WA
Neonatal Erythropoietin And Therapeutic Hypothermia Outcomes in Newborn Brain Injury (NEATO)
Neonatal Erythropoietin And Therapeutic Hypothermia Outcomes Study
Status: Enrolling
Updated: 3/14/2016
Seattle Children's Hospital
mi
from
Seattle, WA
Click here to add this to my saved trials
Neonatal Erythropoietin And Therapeutic Hypothermia Outcomes in Newborn Brain Injury (NEATO)
Neonatal Erythropoietin And Therapeutic Hypothermia Outcomes Study
Status: Enrolling
Updated:  3/14/2016
Stanford University
mi
from
Palo Alto, CA
Neonatal Erythropoietin And Therapeutic Hypothermia Outcomes in Newborn Brain Injury (NEATO)
Neonatal Erythropoietin And Therapeutic Hypothermia Outcomes Study
Status: Enrolling
Updated: 3/14/2016
Stanford University
mi
from
Palo Alto, CA
Click here to add this to my saved trials
Neonatal Erythropoietin And Therapeutic Hypothermia Outcomes in Newborn Brain Injury (NEATO)
Neonatal Erythropoietin And Therapeutic Hypothermia Outcomes Study
Status: Enrolling
Updated:  3/14/2016
UCSF
mi
from
San Francisco, CA
Neonatal Erythropoietin And Therapeutic Hypothermia Outcomes in Newborn Brain Injury (NEATO)
Neonatal Erythropoietin And Therapeutic Hypothermia Outcomes Study
Status: Enrolling
Updated: 3/14/2016
UCSF
mi
from
San Francisco, CA
Click here to add this to my saved trials
D-Cycloserine and Social Skills Training in Autism Spectrum Disorders
A Randomized, Placebo-Controlled Trial of D-Cycloserine for the Enhancement of Social Skills Training in Pervasive Developmental Disorders
Status: Enrolling
Updated:  3/15/2016
Riley Hospital for Children
mi
from
Indianapolis, IN
D-Cycloserine and Social Skills Training in Autism Spectrum Disorders
A Randomized, Placebo-Controlled Trial of D-Cycloserine for the Enhancement of Social Skills Training in Pervasive Developmental Disorders
Status: Enrolling
Updated: 3/15/2016
Riley Hospital for Children
mi
from
Indianapolis, IN
Click here to add this to my saved trials
D-Cycloserine and Social Skills Training in Autism Spectrum Disorders
A Randomized, Placebo-Controlled Trial of D-Cycloserine for the Enhancement of Social Skills Training in Pervasive Developmental Disorders
Status: Enrolling
Updated:  3/15/2016
Cincinnati Children's Hospital Medical Center
mi
from
Cincinnati, OH
D-Cycloserine and Social Skills Training in Autism Spectrum Disorders
A Randomized, Placebo-Controlled Trial of D-Cycloserine for the Enhancement of Social Skills Training in Pervasive Developmental Disorders
Status: Enrolling
Updated: 3/15/2016
Cincinnati Children's Hospital Medical Center
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Preference and Goal Directed Attention Deficit Hyperactivity Disorder Care- Pilot Study
Preference and Goal-Directed Primary Care to Minimize Disparities and Improve Outcomes in ADHD
Status: Enrolling
Updated:  3/15/2016
Children's Hospital of Philadelphia
mi
from
Philadelphia, PA
Preference and Goal Directed Attention Deficit Hyperactivity Disorder Care- Pilot Study
Preference and Goal-Directed Primary Care to Minimize Disparities and Improve Outcomes in ADHD
Status: Enrolling
Updated: 3/15/2016
Children's Hospital of Philadelphia
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Fire Fighter Fatigue Management Program: Operation Fight Fatigue
Fire Fighter Fatigue Management Program: Operation Fight Fatigue
Status: Enrolling
Updated:  3/15/2016
Division of Sleep Medicine; Brigham and Women's Hospital
mi
from
Boston, MA
Fire Fighter Fatigue Management Program: Operation Fight Fatigue
Fire Fighter Fatigue Management Program: Operation Fight Fatigue
Status: Enrolling
Updated: 3/15/2016
Division of Sleep Medicine; Brigham and Women's Hospital
mi
from
Boston, MA
Click here to add this to my saved trials